ES2809598T3 - Composiciones farmacéuticas para el tratamiento de superinfecciones bacterianas post-influenza - Google Patents

Composiciones farmacéuticas para el tratamiento de superinfecciones bacterianas post-influenza Download PDF

Info

Publication number
ES2809598T3
ES2809598T3 ES15817338T ES15817338T ES2809598T3 ES 2809598 T3 ES2809598 T3 ES 2809598T3 ES 15817338 T ES15817338 T ES 15817338T ES 15817338 T ES15817338 T ES 15817338T ES 2809598 T3 ES2809598 T3 ES 2809598T3
Authority
ES
Spain
Prior art keywords
antibiotic
amino acid
seq
combination
flagellin polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES15817338T
Other languages
English (en)
Spanish (es)
Inventor
Jean-Claude Sirard
Christophe Carnoy
François Trottein
Rémi Porte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique
Institut National de la Santé et de la Recherche Médicale
Institut Pasteur
Université de Lille
Original Assignee
Centre National de la Recherche Scientifique
Institut National de la Santé et de la Recherche Médicale
Institut Pasteur
Université de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Institut Pasteur, Université de Lille filed Critical Centre National de la Recherche Scientifique
Application granted granted Critical
Publication of ES2809598T3 publication Critical patent/ES2809598T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
ES15817338T 2014-12-23 2015-12-22 Composiciones farmacéuticas para el tratamiento de superinfecciones bacterianas post-influenza Active ES2809598T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14307154 2014-12-23
PCT/EP2015/080924 WO2016102536A1 (en) 2014-12-23 2015-12-22 Methods and pharmaceutical compositions for the treatment of bacterial superinfections post-influenza

Publications (1)

Publication Number Publication Date
ES2809598T3 true ES2809598T3 (es) 2021-03-04

Family

ID=52432622

Family Applications (1)

Application Number Title Priority Date Filing Date
ES15817338T Active ES2809598T3 (es) 2014-12-23 2015-12-22 Composiciones farmacéuticas para el tratamiento de superinfecciones bacterianas post-influenza

Country Status (5)

Country Link
US (1) US10736937B2 (cg-RX-API-DMAC10.html)
EP (1) EP3236988B8 (cg-RX-API-DMAC10.html)
JP (2) JP6912379B2 (cg-RX-API-DMAC10.html)
ES (1) ES2809598T3 (cg-RX-API-DMAC10.html)
WO (1) WO2016102536A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102884852B1 (ko) * 2018-04-16 2025-11-14 에프. 호프만-라 로슈 아게 킬레이트화된 방사성핵종에 대한 항체
FR3114970B1 (fr) 2020-10-08 2023-06-30 Univ Tours Combinaison d’anticorps inhalés avec des agents immunomodulateurs pour le traitement ou la prévention d’inféctions respiratoires
US20240277801A1 (en) 2021-06-30 2024-08-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Aerosol composition for pulmonary delivery of flagellin
WO2025172452A1 (en) 2024-02-14 2025-08-21 Institut National de la Santé et de la Recherche Médicale Combination for treating bacterial infection due to pseudomonas aeruginosa antibiotic-resistant strain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101684447B1 (ko) * 2008-06-25 2016-12-08 인썸(인스티튜트 내셔날 드 라 싼테 에 드 라 리셰르셰메디칼르) 면역애쥬번트인 플라겔린 기반의 화합물 및 이의 용도
KR101768118B1 (ko) * 2010-06-25 2017-08-14 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) 기도 감염의 치료를 위한 방법 및 약학 조성물
EP2903622A1 (en) 2012-10-03 2015-08-12 INSERM - Institut National de la Santé et de la Recherche Médicale Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza with invariant nkt cell agonists
EP2903634A1 (en) 2012-10-03 2015-08-12 INSERM - Institut National de la Santé et de la Recherche Médicale Methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza
JP6274904B2 (ja) * 2014-02-25 2018-02-07 キヤノン株式会社 固体撮像装置及び撮像システム

Also Published As

Publication number Publication date
EP3236988B8 (en) 2020-08-19
WO2016102536A1 (en) 2016-06-30
JP2018505861A (ja) 2018-03-01
EP3236988B1 (en) 2020-06-24
US10736937B2 (en) 2020-08-11
US20180264077A1 (en) 2018-09-20
JP2020138968A (ja) 2020-09-03
JP6912379B2 (ja) 2021-08-04
EP3236988A1 (en) 2017-11-01

Similar Documents

Publication Publication Date Title
US9919029B2 (en) Methods and pharmaceutical compositions for the treatment of bacterial infections
US20230382961A1 (en) Cath2 derivatives
JP2020138968A (ja) インフルエンザ後の細菌重感染を処置するための方法及び医薬組成物
EP2872162A1 (en) Colicins for treating bacterial infections
EP3809851A1 (en) Lysins and derivatives thereof resensitize staphylococcus aureus and gram-positive bacteria to antibiotics
JP2015531384A (ja) インバリアントnkt細胞アゴニストを用いたインフルエンザ後の細菌重複感染の予防的処置のための方法及び薬学的組成物
US12571020B2 (en) Genetically engineered microorganisms that overexpress microcin-mge and methods of purification and use
US12576128B2 (en) Genetically engineered microorganisms and methods of use
BR112012033121B1 (pt) Métodos e composições farmacêuticas para o tratamento de infecções do trato respiratório.
US11130781B2 (en) Antimicrobial peptides and their use
WO2023275292A2 (en) Aerosol composition for pulmonary delivery of flagellin
US11306067B2 (en) Diphenyl substituted thiophene-2-amide derivatives and pharmaceutical compositions thereof useful as antimicrobial
US20180344807A1 (en) Methods and pharmaceutical compositions for the treatment of acute exacerbations of chronic obstructive pulmonary disease
WO2025172452A1 (en) Combination for treating bacterial infection due to pseudomonas aeruginosa antibiotic-resistant strain
EP3847247A1 (en) Infection-induced endothelial amyloid compositions as antimicrobials
RU2792679C1 (ru) Бактерицидная фармацевтическая композиция для парентерального применения в форме лиофилизата с эндолизином
BR102015028254A2 (pt) peptídeo sintético e seu uso como antimicrobiano
JP2012180302A (ja) 抗グラム陰性菌剤
Díez-Martínez et al. Chemotherapy with Phage Lysins Reduces Pneumococcal Colonization of the Respiratory Tract
Tonnaer et al. Factors contributing to the pathogenesis of otitis media, with emphasis on pneumococci
EP3724330A1 (en) Compositions and methods comprising lysin plycp025 and derivatives thereof
BR122024005711A2 (pt) Derivados de cath2